ZTO Express
ZTO
19.80
+0.12
+0.61%
ZTO Express
US · ZTO
#1135 by market cap
Listed 2016
19.80
+0.12
+0.61%
Live - 5344 symbols - heartbeat 202s ago
· 2026-10-08 04:01
Pre-market
19.61
-0.96%
After-hours
19.80
0.00%
Overnight
19.61
-0.96%
- Market cap
- 15.12B
- P/E (TTM)i
- 10.36
- P/Bi
- 1.59
- EPSi
- 1.67
- Div yieldi
- 3.58%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on ZTO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.11, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.88% YoY
Margins
- Gross margin
- 24.99%
- Operating margin
- 21.33%
- Net margin
- 18.70%
Key ratios & quality
- Enterprise valuei
- 699.83M
- PEG ratioi
- 1.03
- Altman Z-Scorei
- 2.11
PEG uses trailing P/E against the 3-year net income growth rate (10.07%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.60B | 22.11B | 25.21B | 30.41B | 35.38B | 38.42B | 44.28B | 49.10B |
| Gross profit | 5.36B | 6.62B | 5.84B | 6.59B | 9.04B | 11.66B | 13.72B | 12.27B |
| Selling & admin expenses | 1.21B | 1.55B | 1.66B | 1.88B | 2.08B | 2.43B | 2.69B | 2.64B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.33B | 5.46B | 4.75B | 5.50B | 7.74B | 10.01B | 11.78B | 10.47B |
| Pretax profit | 5.34B | 6.76B | 5.03B | 5.74B | 8.29B | 10.69B | 11.68B | 11.05B |
| Tax | 929.13M | 1.08B | 689.83M | 1.01B | 1.63B | 1.94B | 2.85B | 1.91B |
| Net profit | 4.39B | 5.67B | 4.33B | 4.70B | 6.66B | 8.75B | 8.89B | 9.24B |
| Basic EPS | 6 | 7 | 5 | 6 | 8 | 11 | 11 | 11 |
| Diluted EPS | 5.82 | 7.23 | 5.42 | 5.80 | 8.36 | 10.60 | 10.70 | 11.19 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 10.89B | 11.83B | 11.86B | 14.51B | 13.28B | 14.55B |
| Gross profit | 2.69B | 2.94B | 2.96B | 3.68B | 3.24B | 3.73B |
| Selling & admin expenses | 737.51M | 623.59M | 632.58M | 643.88M | 815.66M | 556.67M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.41B | 2.41B | 2.41B | 3.19B | 2.49B | 3.28B |
| Pretax profit | 2.57B | 2.51B | 2.68B | 3.29B | 2.69B | 3.36B |
| Tax | 531.57M | 575.53M | 160.00M | 638.13M | 552.18M | 258.64M |
| Net profit | 2.04B | 1.96B | 2.54B | 2.69B | 2.16B | 3.08B |
| Basic EPS | 3 | 2 | 3 | 3 | 3 | 4 |
| Diluted EPS | 2.44 | 2.37 | 3.10 | 3.31 | 2.68 | 3.76 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 21.23B | 20.10B | 22.32B | 18.67B | 24.48B | 26.95B | 30.35B | 33.96B |
| Cash & ST investments | 18.22B | 16.38B | 17.90B | 12.57B | 17.45B | 19.79B | 22.31B | 25.63B |
| Inventory | 43.81M | 43.85M | 53.07M | 82.96M | 40.54M | 28.07M | 38.57M | 40.65M |
| Total assets | 39.68B | 45.89B | 59.20B | 62.77B | 78.52B | 88.47B | 92.34B | 91.02B |
| Total current liabilities | 5.14B | 6.68B | 9.35B | 13.00B | 16.41B | 20.06B | 28.27B | 22.87B |
| Short-term debt | -- | 298.73M | 2.01B | 3.88B | 5.82B | 7.95B | 16.97B | 11.07B |
| Long-term debt | -- | -- | -- | -- | 6.79B | 7.03B | -- | 142.11M |
| Total liabilities | 5,413,308,000.00 | 7,487,105,000.00 | 10,105,052,000.00 | 13,844,762,000.00 | 24,051,116,000.00 | 28,184,813,000.00 | 29,665,497,000.00 | 23,887,584,000.00 |
| Total equity | 34.27B | 38.40B | 49.10B | 48.93B | 54.47B | 60.28B | 62.67B | 67.14B |
| Retained earnings | 11.05B | 16.73B | 21.04B | 22.72B | 29.46B | 36.30B | 39.10B | 42.92B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 30.57B | 34.52B | 33.17B | 33.96B | 38.85B | 40.08B |
| Cash & ST investments | 23.02B | 26.52B | 25.29B | 25.63B | 30.49B | 31.31B |
| Inventory | 35.52M | 47.90M | 48.25M | 40.65M | 39.04M | 31.00M |
| Total assets | 93.15B | 94.62B | 90.54B | 91.02B | 97.78B | 98.74B |
| Total current liabilities | 29.06B | 28.45B | 24.07B | 22.87B | 23.69B | 23.97B |
| Short-term debt | 16.70B | 18.37B | 11.78B | 11.07B | 11.21B | 11.71B |
| Long-term debt | 17.00M | 180.00M | 289.35M | 142.11M | 10.36B | 10.20B |
| Total liabilities | 30,283,714,000.00 | 29,764,954,000.00 | 25,175,818,000.00 | 23,887,584,000.00 | 34,901,317,000.00 | 35,005,378,000.00 |
| Total equity | 62.87B | 64.86B | 65.37B | 67.14B | 62.88B | 63.74B |
| Retained earnings | 38.42B | 40.35B | 41.15B | 42.92B | 39.86B | 42.91B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.40B | 6.30B | 4.95B | 7.22B | 11.48B | 13.36B | 11.43B | 11.97B |
| Depreciation & amortization | 853.72M | 1.26B | 1.84B | 2.22B | 2.67B | 2.88B | 3.02B | 3.38B |
| Free cash flow | 422.78M | 1.08B | -4.26B | -2.11B | 4.07B | 6.69B | 5.53B | 5.89B |
| Dividends paid | -895.14M | -1.27B | -1.65B | -1.35B | -1.32B | -2.07B | -5.61B | -3.76B |
| Stock buybacks / issuance | 8.12B | -762.89M | 8.54B | -3.81B | -84.55M | -1.01B | -1.16B | -1.25B |
| Ending cash balance | 4.62B | 5.28B | 14.36B | 9.77B | 12.60B | 13.05B | 13.53B | 10.05B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.36B | 2.17B | 3.21B | 4.23B | 2.79B | 4.56B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 2.36B | -903.92M | 3.21B | -1.85B | 2.79B | 1.80B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 12.46B | 13.33B | 9.42B | 10.05B | 11.44B | 9.96B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.75 | 15.65 | 9.88 | 9.74 | 13.26 | 15.63 | 14.72 | 14.30 |
| ROA %i | 13.38 | 13.26 | 8.21 | 7.80 | 9.64 | 10.65 | 9.92 | 10.02 |
| ROIC %i | 14.56 | 13.98 | 8.74 | 8.72 | 10.91 | 12.01 | 10.96 | 11.15 |
| 5-year avg ROE %i | 17.12 | 17.83 | 14.21 | 13.27 | 12.88 | 12.85 | 12.66 | 13.55 |
| EBIT margin %i | 30.32 | 30.56 | 20.11 | 19.29 | 23.96 | 28.58 | 27.13 | 23.02 |
| FCF / sales %i | 2.40 | 4.87 | -- | -- | 11.50 | 17.42 | 12.48 | 12.00 |
| Current ratioi | 4.13 | 3.01 | 2.39 | 1.44 | 1.49 | 1.34 | 1.07 | 1.49 |
| Quick ratioi | 3.98 | 2.87 | 2.24 | 1.32 | 1.34 | 1.22 | 1.01 | 1.40 |
| Debt / assetsi | 0.00 | 1.75 | 4.24 | 7.07 | 16.71 | 17.45 | 18.78 | 12.61 |
| LT debt / equityi | -- | 1.32 | 1.03 | 1.14 | 13.51 | 12.52 | 0.61 | 0.61 |
| Interest coveragei | 6,842.58 | -- | 143.60 | 46.37 | 44.49 | 37.92 | 35.55 | 45.46 |
| Revenue CAGR (3Y) %i | 42.48 | 31.21 | 24.52 | 19.98 | 16.96 | 15.07 | 13.35 | 11.54 |
| Net income CAGR (3Y) %i | 48.75 | 40.32 | 10.92 | 2.75 | 6.27 | 26.60 | 22.86 | 10.07 |
| FCF CAGR (3Y) %i | -13.71 | -- | -- | -- | 55.68 | -- | -- | 13.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.88 | 14.22 | 14.35 | 14.30 | 14.97 | 16.26 |
| ROA %i | 10.42 | 9.54 | 9.78 | 10.02 | 9.75 | 10.75 |
| ROIC %i | 11.84 | 10.44 | 11.00 | 11.15 | 10.91 | 11.85 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 27.80 | 25.45 | 24.31 | 23.02 | 22.15 | 22.54 |
| FCF / sales %i | 12.96 | 9.60 | 9.78 | 12.00 | 12.27 | 16.65 |
| Current ratioi | 1.05 | 1.21 | 1.38 | 1.49 | 1.64 | 1.67 |
| Quick ratioi | 0.86 | 1.02 | 1.13 | 1.40 | 1.38 | 1.42 |
| Debt / assetsi | 18.34 | 19.95 | 13.65 | 12.61 | 22.29 | 22.32 |
| LT debt / equityi | 0.61 | 0.78 | 0.90 | 0.61 | 17.04 | 16.23 |
| Interest coveragei | 38.92 | 38.64 | 39.39 | 45.46 | 49.58 | 60.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:01:02 · For reference only, not investment advice and not tailored to your situation.